This sort of business has always been about volumes ie is low...

This sort of business has always been about volumes ie is low margin, high volume business they are in for bio plastics, includes bio degrable plastic bags. Huge worldwide market that is enjoying strong double digit growth but from low overall penetration of plastics business. Cardia as new player trying to break into this market which has strong market growth outlook due to govts pushing to reduce the carbon footprint by encouraging bio degradeable plastics etc.

The key thing is their is huge contracts on offer. E.g those chinese trials turn into contracts will generate substantial volumes. Will give them credit that they are at least focusing on the right big markets (e.g. china) but need to move from trials to contracts.

All about when with this stock. On my radar for long term investment at some stage after cashing out while ago but looking for signs closer to moving to breakeven which means winning a few big contracts. Reckon in 3 years will be a great stock given market dynamics/trends, but problem is until gets those big contracts (not another trial), cash burn means will continue to need to raise cash which means dilution.